San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium

Find SABCS18 on Social Media



Exhibit

Symposia

Workshops

Organiser

Sponsor



Since 1977, the Symposium’s mission has been to provide state-of-the-art information on breast cancer research. From a one-day regional conference, the Symposium has grown to a five-day program attended by a broad international audience of academic and private researchers and physicians from over 90 countries.

The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for a broad spectrum of researchers, health professionals, and those with a special interest in breast cancer.

In 2007, the Cancer Therapy & Research Center (CTRC) at UT Health Science Center San Antonio and the American Association for Cancer Research (AACR) announced a collaboration for the future of the San Antonio Breast Cancer Symposium®. The Symposium was renamed the CTRC-AACR San Antonio Breast Cancer Symposium. Complementing the clinical strengths of the highly regarded annual San Antonio Breast Cancer Symposium®, the AACR's scientific prestige in basic, translational and clinical cancer research will create a unique and comprehensive scientific meeting that will advance breast cancer research for the benefit of patients.

In 2005, Baylor College of Medicine became a joint sponsor of the symposium and will remain in the CTRC-AACR collaboration.

C. Kent Osborne, MD, Director, Professor of Medicine and Molecular and Cellular Biology, Director, Dan L. Duncan Cancer Center, Baylor College of Medicine, Virginia G. Kaklamani, MD, Professor of Medicine, Division of Hematology/Oncology, UT Health San Antonio and Carlos L. Arteaga, MD, Director, Harold C. Simmons Comprehensive Cancer Center, and Associate Dean Cancer Programs, UT Southwestern Medical Center are Co-Directors of the Symposium.
This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.
Any remaining funds at the conclusion of the CME activity will be used for educational research purposes.

Find the programme here!

Registration for this event here!




Related articles

More events

JFR 2024

Fri, 4 Oct 2024 - Mon, 7 Oct 2024


Place de la Porte Maillot 2
Paris, 75017
France
Cancer Forum 2024

Mon, 7 Oct 2024 - Wed, 9 Oct 2024


Rämistrasse 71
Zürich, 8006
Switzerland
EACR Conference - Cancer Metabolism 2024

Tue, 8 Oct 2024 - Thu, 10 Oct 2024


Abandoibarra Etorbidea 4
Bilbo, 48011
Spain
EUSOMII BRACCO AI CONTEST 2024

Thu, 10 Oct 2024 - Thu, 10 Oct 2024


Piazza Vittorio Emanuele II 5
Pisa, 56125
Italy
EuSoMII Annual Meeting 2024

Fri, 11 Oct 2024 - Sat, 12 Oct 2024


Piazza Vittorio Emanuele II 5
Pisa, 56125
Italy
Imaging Update in Seville 2024

Tue, 15 Oct 2024 - Wed, 16 Oct 2024


Calle San Fernando 2
Sevilla, 41004
Spain
Baltic Congress of Radiology 2024

Thu, 17 Oct 2024 - Sat, 19 Oct 2024


Elizabetes iela 55, Centra rajons
Rīga, LV-1010
Latvia